Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary

Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary

<p>Abstract</p> <p>Aim</p> <p>The objective of this observational study was to assess the status of glycemic control and associated patient-reported outcomes in ambulatory Hungarian patients with type 2 diabetes mellitus (T2DM) who were prescribed either a sulfonylurea...

Full description

Bibliographic Details
Main Authors:	Karve Sudeep, Phatak Hemant, Yin Don, Nagy Laszlo, Erdesz Diana, Jermendy György, Engel Samuel, Balkrishnan Rajesh
Format:	Article
Language:	English
Published:	BMC 2008-10-01
Series:	Health and Quality of Life Outcomes
Online Access:	http://www.hqlo.com/content/6/1/88

Similar Items

Preventive Metformin Monotherapy Medication Prescription, Redemption and Socioeconomic Status in Hungary in 2018–2019: A Cross-Sectional Study
by: Csilla Nagy, et al.
Published: (2021-02-01)

Hypoglycemic encephalopathy caused by overdose of metformin in an adolescent
by: Jing-Xue Li, et al.
Published: (2020-01-01)

Safety and Efficacy of Hypoglycemic Therapy: Place of Metformin
by: K.A. Zuyev, et al.
Published: (2013-10-01)

Combination of Metformin and Momordica Charantia On in Vivo Hypoglycemic Effecct
by: Chao-Chu Li, et al.
Published: (2015)

Assessment of cardiometabolic risk among shift workers in Hungary
by: Jermendy György, et al.
Published: (2012-02-01)

Trends in Ambulatory Prescribing of Antiplatelet Therapy among US Ischemic Stroke Patients: 2000–2007
by: Sudeep Karve, et al.
Published: (2012-01-01)

Pharmacoeconomic analysis of modern oral hypoglycemic agents with inadequate glycemic control on metformin
by: M. F. Kalashnikova, et al.
Published: (2019-08-01)

Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus
by: Lingfeng Yang, et al.
Published: (2021-08-01)

Metformin Monotherapy Downregulates Diabetes-Associated Inflammatory Status and Impacts on Mortality
by: Anteneh Mehari Tizazu, et al.
Published: (2019-05-01)

Changes in the incidence and prevalence of type 1 and type 2 diabetes among 2 million children and adolescents in Hungary between 2001 and 2016 – a nationwide population-based study
by: László Barkai, et al.
Published: (2019-10-01)

Comparison of effect of simvastatin and metformin monotherapy on lipid profile and testosterone levels in polycystic ovary syndrome
by: Veena Singh, et al.
Published: (2012-06-01)

Influence of Sodium Alginate on Hypoglycemic Activity of Metformin Hydrochloride in the Microspheres Obtained by the Spray Drying
by: Marta Szekalska, et al.
Published: (2016-01-01)

Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysis.
by: Elizabeth S Mearns, et al.
Published: (2015-01-01)

Territorial Differences of Rural Cities and the Development of Transport Infrastructure in Hungary
by: LÁSZLÓ PÉLI, et al.
Published: (2015-12-01)

Dissimilar impact of type 2 diabetes on cardiovascular outcomes according to age categories: a nationwide population study from Hungary
by: Zoltán Kiss, et al.
Published: (2018-07-01)

Dose distribution and up‐titration patterns of metformin monotherapy in patients with type 2 diabetes
by: Kristy Iglay, et al.
Published: (2020-01-01)

Diabetes Monotherapies versus Metformin-Based Combination Therapy for the Treatment of Type 2 Diabetes
by: Singh AK, et al.
Published: (2021-07-01)

Comparison of the Efficacy of Glimepiride, Metformin, and Rosiglitazone Monotherapy in Korean Drug-Naïve Type 2 Diabetic Patients: The Practical Evidence of Antidiabetic Monotherapy Study
by: Kun Ho Yoon, et al.
Published: (2011-02-01)

Vascular memory: can we broaden the concept of the metabolic memory?
by: Jermendy György
Published: (2012-07-01)

Efficacy of the treatment with dapagliflozin and metformin compared to metformin monotherapy for weight loss in patients with class III obesity: a randomized controlled trial
by: Aldo Ferreira-Hermosillo, et al.
Published: (2020-02-01)

Nocturnal Hypoglycaemia in Patients with Diabetes Mellitus: Database Analysis of a Cohort Using Telemedicine Support for Self-Monitoring of Blood Glucose over a 10-Year-Long Period
by: Gyorgy Jermendy, et al.
Published: (2021-02-01)

Evaluation of Ischemic Stroke-Related Healthcare Utilization Trends Using Recent National Data: 2000 – 2005
by: Karve, Sudeep
Published: (2009)

Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus
by: Tian Li, et al.
Published: (2021-01-01)

Comparison of effect of simvastatin and metformin monotherapy on lipid profile and testosterone levels in polycystic ovary syndrome
by: Veena Singh
Published: (2012-01-01)

Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes
by: Jia Liu, et al.
Published: (2017-01-01)

Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China
by: J. Ma, et al.
Published: (2014-01-01)

Different Changes of Risks for Stroke and Myocardial Infarction in Patients With Type 2 Diabetes in Hungary Between the Two Periods of 2001–2004 and 2010–2013
by: Zoltan Kiss, et al.
Published: (2019-03-01)

Agencies and the Politics of Agencification in Hungary
by: György HAJNAL
Published: (2011-12-01)

Comparative evaluation of biphasic insulin with metformin and triple oral hypoglycemic agents (OHA) in type 2 diabetes patients
by: Sirajudeen Shaik Alavudeen, et al.
Published: (2020-02-01)

Plenodomus biglobosus on oilseed rape in Hungary
by: Bianka BAGI, et al.
Published: (2020-07-01)

Efficacy and safety of twice-daily treatment with canagliflozin, a sodium glucose co-transporter 2 inhibitor, added on to metformin monotherapy in patients with type 2 diabetes mellitus
by: Rong Qiu, MD, PhD, et al.
Published: (2014-06-01)

Effect of Repaglinide and Metformin Combination Therapy Compare With Repaglinide Monotherapy in Type 2 Diabetes Mellitus Treatment
by: Yi-Chiao Su, et al.
Published: (2017)

Which is better, high‐dose metformin monotherapy or low‐dose metformin/linagliptin combination therapy, in improving glycemic variability in type 2 diabetes patients with insufficient glycemic control despite low‐dose metformin monotherapy? A randomized, cross‐over, continuous glucose monitoring‐based pilot study
by: Hiroshi Takahashi, et al.
Published: (2019-05-01)

Sustainability and Control Issues of the Financial Management of Local Governments – Through Hungary’s Example
by: Lentner Csaba, et al.
Published: (2019-06-01)

Cost-effectiveness of second-line agents added to metformin for cardiovascular risk reduction
by: Ming-Hung Tsai, et al.
Published: (2018)

Water temperatures of the Danube and Tisza Rivers in Hungary
by: György Lovász
Published: (2012-12-01)

Interaction Between the Study and the Practice of PA in Hungary
by: György HAJNAl
Published: (2006-10-01)

Metformin monotherapy significantly decreases epicardial adipose tissue thickness in newly diagnosed type 2 diabetes patients
by: Murat Ziyrek, et al.
Published: (2019-06-01)

Metformin monotherapy significantly decreases epicardial adipose tissue thickness in newly diagnosed type 2 diabetes patients
by: Murat Ziyrek, et al.
Published: (2019-06-01)

Release from 'prison' in Hungary
by: Nagy Anita
Published: (2015-01-01)

Cannot write session to /tmp/vufind_sessions/sess_3bu3c771ml26ssv5vmt6ii28f0